Fluorescence‐based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations

Isolation of the gene for cystic fibrosis (CF), the cystic fibrosis transmembrane conductance regulator (CFTR), provided a basis for analyzing its molecular pathology and resulted in the identification of < 400 mutations associated with disease. Except for the ΔF508 mutation, no other single mutation accounts for > 5% of CF chromosomes in most populations, and most mutation frequencies are < 1%. A strategy based on multiplex PCR followed by multiplex allele‐specific oligonucleotide probe ligation was used to detect 30 mutations, distributed throughout ten exons and seven introns of the CFTR gene, that together account for > 96% of CF mutant chromosomes worldwide. Mutations were detected by competitive oligonucleotide probe ligation to detect normal and/or mutant genotypes in one reaction. Three probes (one common and two allelic probes) were needed for analysis of each mutation. Probes hybridized to target DNA were joined by a thermostable ligase if there were no mismatches at their junctions; temperature cycling resulted in a linear increase in product. Common probes were labeled with fluorochromes, and allelic probes each had different lengths. Ligation products were analyzed electrophoretically on a fluorescent DNA sequencer. The results show that combined PCR and probe ligation amplification rapidly and reliably screen for CF homozygotes and carriers. © Wiley‐Liss, Inc.

[1]  L. Tsui,et al.  Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: A report from the cystic fibrosis genetic analysis consortium , 1992, Human mutation.

[2]  M. Takahashi,et al.  Thermophilic DNA ligase. Purification and properties of the enzyme from Thermus thermophilus HB8. , 1984, The Journal of biological chemistry.

[3]  U Landegren,et al.  A ligase-mediated gene detection technique. , 1988, Science.

[4]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[5]  L. Tsui,et al.  The spectrum of cystic fibrosis mutations. , 1992, Trends in genetics : TIG.

[6]  D. Y. Wu,et al.  The ligation amplification reaction (LAR)--amplification of specific DNA sequences using sequential rounds of template-dependent ligation. , 1989, Genomics.

[7]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[8]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[9]  Wallace Rb,et al.  Oligonucleotide hybridization techniques. , 1987 .

[10]  W. Giusti,et al.  Synthesis and characterization of 5'-fluorescent-dye-labeled oligonucleotides. , 1993, PCR methods and applications.

[11]  H. Birnboim,et al.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA. , 1979, Nucleic acids research.

[12]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[13]  G. Cutting,et al.  Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. , 1992, American journal of human genetics.

[14]  M. Welsh,et al.  Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. , 1991, Science.

[15]  K. Klinger,et al.  Identification of the M1101K mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and complete detection of cystic fibrosis mutations in the Hutterite population. , 1993, American journal of human genetics.

[16]  Henry A. Erlich,et al.  Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.

[17]  C. Férec,et al.  Detection of over 98% cystic fibrosis mutations in a Celtic population , 1992, Nature Genetics.

[18]  A. Beaudet,et al.  Benign missense variations in the cystic fibrosis gene. , 1990, American journal of human genetics.

[19]  D. Johns,et al.  Pitfalls in the molecular genetic diagnosis of Leber hereditary optic neuropathy (LHON). , 1993, American journal of human genetics.

[20]  F. Barany,et al.  Cloning, overexpression and nucleotide sequence of a thermostable DNA ligase-encoding gene. , 1991, Gene.

[21]  R. Williamson.  Universal community carrier screening for cystic fibrosis? , 1993, Nature Genetics.

[22]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[23]  U Landegren,et al.  Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Tsui,et al.  Identification of the cystic fibrosis gene: chromosome walking and jumping. , 1989, Science.

[25]  D. Y. Wu,et al.  Specificity of the nick-closing activity of bacteriophage T4 DNA ligase. , 1989, Gene.

[26]  C. Springer,et al.  Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. , 1992, American journal of human genetics.

[27]  F. Barany.  Genetic disease detection and DNA amplification using cloned thermostable ligase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Tsui,et al.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. , 1991, Genomics.